The impact of METTL3 and NEDD1 on DLBCL tumorigenesis was examined in vivo (only SU‐DHL‐8 cells were used for in vivo experiments to reduce unnecessary sacrifices). Here, METTL3 is linked to diffuse large B-cell lymphoma.